Beschreibung
This book offers a multidisciplinary look at the much-debated concept of "personalized medicine". By combining a humanistic and a scientific approach, the book builds up a multidimensional way to understand the limits and potentialities of a personalized approach in medicine and healthcare. The book reflects on personalized medicine and complex diseases, the relationship between personalized medicine and the new bio-technologies, personalized medicine and personalized nutrition, and on some ethical, political, economic, and social implications of personalized medicine. This volume is of interest to researchers from several disciplines including philosophy, bio-medicine, and the social sciences. Chapter 16, "The Impact of Fantasy" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
Autorenporträt
Chiara Beneduce is a postdoctoral researcher at the Center for the History of Philosophy and Science of Radboud University, Nijmegen (The Netherlands) and teaching assistant in the Philosophy of Science at Campus Bio-Medico University of Rome (Italy). Her research is placed at the intersection of the History of Philosophy, the History of Science, and the Philosophy of Medicine. Her research is currently supported by the NWO-Veni Grant number VI.Veni.191F.005 for the project "The Sense of Touch. From Anomaly to Paradigm". Marta Bertolaso is Professor of Philosophy of Science at Campus Bio-Medico University of Rome (Italy) and Adjunct Professor at the University of Bergen in collaboration with the CCBIO (Centre for Cancer Biomarkers). After a degree in Biological Sciences and some years in the lab, she developed her academic career in the Philosophy of the Life Sciences. Her expertise in especially in the philosophy of cancer, scientific practice and the philosophy of complex organized systems. Supported by visiting or scholar fellowships, she has worked in prestigious international research centers for the Philosophy of Science in Pittsburgh (PA, USA), Exeter (UK), Paris (France), Vienna (Austria), and Milan (e.g. IFOM of the European Oncology Institute).
